Natural Biocon (India) Ltd
₹ 3.44
-1.99%
22 May
- close price
About
Incorporated in 1992, Natural Biocon Ltd is engaged in the trading of agricultural
produce.[1]
Key Points
- Market Cap ₹ 8.87 Cr.
- Current Price ₹ 3.44
- High / Low ₹ 16.0 / 3.09
- Stock P/E
- Book Value ₹ 11.9
- Dividend Yield 0.00 %
- ROCE -0.13 %
- ROE -0.13 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.29 times its book value
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 9.36%
- Company has a low return on equity of 0.23% over last 3 years.
- Company has high debtors of 736 days.
- Promoter holding has decreased over last 3 years: -11.9%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.15 | 1.04 | 0.45 | -0.00 | 0.13 | 0.48 | 1.25 | 13.53 | 8.35 | 2.55 | |
| 0.05 | 0.04 | 0.04 | 0.34 | 0.03 | 0.13 | 0.39 | 1.00 | 13.30 | 8.29 | 2.59 | |
| Operating Profit | -0.00 | 0.11 | 1.00 | 0.11 | -0.03 | -0.00 | 0.09 | 0.25 | 0.23 | 0.06 | -0.04 |
| OPM % | -0.00% | 73.33% | 96.15% | 24.44% | -0.00% | 18.75% | 20.00% | 1.70% | 0.72% | -1.57% | |
| -0.00 | -0.00 | -0.00 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Depreciation | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Profit before tax | -0.00 | 0.11 | 1.00 | 0.12 | -0.03 | -0.00 | 0.09 | 0.25 | 0.23 | 0.06 | -0.04 |
| Tax % | 27.27% | 30.00% | 41.67% | 166.67% | 22.22% | 28.00% | 30.43% | 33.33% | -0.00% | ||
| -0.00 | 0.08 | 0.70 | 0.07 | -0.08 | -0.00 | 0.07 | 0.18 | 0.15 | 0.04 | -0.04 | |
| EPS in Rs | -0.00 | 0.07 | 0.62 | 0.06 | -0.07 | -0.00 | 0.06 | 0.16 | 0.13 | 0.02 | -0.02 |
| Dividend Payout % | -0.00% | -0.00% | 81.21% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 81% |
| 3 Years: | 27% |
| TTM: | -69% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -200% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -18% |
| 1 Year: | -69% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 25.78 | 25.78 |
| Reserves | -0.00 | 0.01 | 0.64 | 0.64 | 0.61 | 0.61 | 0.68 | 0.86 | 1.01 | 6.09 | 4.95 |
| -0.00 | -0.00 | -0.00 | 0.82 | 0.68 | 0.36 | 0.16 | 0.15 | 0.07 | 0.28 | 0.38 | |
| 0.03 | 0.13 | 0.42 | 0.19 | 0.05 | 0.04 | 0.08 | 1.13 | 4.32 | 6.37 | 5.73 | |
| Total Liabilities | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 36.84 |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.01 | 0.01 | 0.01 | -0.00 | 0.01 | |
| CWIP | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 21.12 | 21.12 |
| 8.11 | 8.22 | 9.14 | 9.73 | 9.42 | 9.09 | 8.99 | 10.21 | 13.47 | 14.11 | 12.42 | |
| Total Assets | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 36.84 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.18 | 0.21 | -0.12 | 1.30 | 0.03 | |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 | -0.00 | -21.11 | -0.13 | |
| -0.00 | -0.07 | -0.07 | 0.75 | -0.14 | -0.32 | -0.00 | -0.02 | -0.09 | 19.67 | 0.09 | |
| Net Cash Flow | 0.04 | 0.15 | -0.11 | -0.11 | 0.01 | -0.00 | 0.17 | 0.19 | -0.21 | -0.14 | -0.01 |
| Free Cash Flow | 0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.17 | 0.21 | -0.12 | 1.30 | 0.01 |
| CFO/OP | 218% | 26% | -736% | -500% | 222% | 112% | -22% | 2,200% | -75% |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0.00 | -0.00 | 357.98 | 632.67 | 1,460.00 | 372.60 | 183.96 | 131.38 | 247.41 | 735.73 | |
| Inventory Days | 821.25 | 547.50 | 381.59 | 4.61 | 8.40 | -0.00 | |||||
| Days Payable | -0.00 | -0.00 | 423.07 | 117.92 | 270.17 | ||||||
| Cash Conversion Cycle | 821.25 | 547.50 | 357.98 | 632.67 | 1,460.00 | 372.60 | 142.48 | 18.07 | -14.36 | 735.73 | |
| Working Capital Days | 7,665.00 | 2,238.67 | 572.07 | 681.33 | 3,818.46 | 357.40 | 134.32 | 49.10 | 14.86 | -131.69 | |
| ROCE % | 0.97% | 8.55% | 0.97% | -0.24% | -0.00% | 0.73% | 2.03% | 1.85% | 0.27% | -0.13% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Inventory (Stock-in-Trade) INR Lacs |
|
|||||||
| Number of Permanent Employees count |
||||||||
| Purchase of Stock-in-Trade INR Lacs |
||||||||
| Revenue from Operations (Gross Sales) INR Lacs |
||||||||
| Transportation Expenses INR Lacs |
||||||||
| Trade Receivables Turnover Ratio times |
||||||||
| Trade Payables Turnover Ratio times |
||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for AGM
11 May - Board meeting on 18 May 2026 to approve annual report, AGM notice, and book closure dates.
-
Audited Financial Results For The Quarter And Year Ended March 2026
9 May - Board approved FY26 audited standalone results on 9 May 2026; auditors issued unmodified opinion.
-
Board Meeting Outcome for Audited Financial Results Along With Auditors Report For The Quarter And Year Ended March 2026
9 May - Board approved FY26 audited standalone results on 9 May 2026; loss Rs4 lakh, unmodified opinion.
-
Board Meeting Intimation for Audited Results And Audit Report
30 Apr - Board meeting to approve FY26 audited results rescheduled to 9 May 2026.
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
28 Apr - Company confirms it is not a large corporate under SEBI debt-fundraising circular.
Business Overview:[1][2]
NBL is engaged in the business of agricultural activities, which deals in extracting, processing,
and manufacturing agrochemicals and natural alkaloids—like nicotine, caffeine, morphine, and others—from plants, seeds, and agricultural produce. It also deals in barley malt, maltose,
malt sugar, and their derivatives, with operations covering import, export, procurement, assembly, and trade of these products.